60
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
733985
MabTrix is a biopharmaceutical company
Dorit Landstein: CEO
Yeda Research and Development Co. Ltd
About the Company
MabTrix is a preclinical stage biopharmaceutical company aiming to develop an innovative, function-blocking therapeutic monoclonal antibody (MAb) for inflammatory bowel disease (IBD) as the initial indication. The company’s mission is to develop a novel MAb that specifically inhibits enzymatic activity of matrix metalloprotease (MMP) 9 by binding
to the catalytic site of the activated enzyme.MabTrix was established in the FutuRx incubator in December 2015.
